Study on Vascular Aging and Pharmaceutical Interventions

Vascular aging is an age-dependent decline in vascular structure and function. It is one of the most critical determinants of age-related cardiovascular diseases, including hypertensive and atherosclerotic diseases, frank arteriosclerosis, arterial stiffness, and endothelial dysfunction. New findings offer an understanding of the mechanisms controlling the aging process of blood vessels and point to drug possibilities. Objective To identify molecular factors contributing to end vessel aging or test compounds modulating vascular stiffness/senescence markers. Methods Moreover, through the study of molecular changes in the RSC, the main mechanisms of the disease, such as oxidative stress, extracellular matrix alterations, and endothelial cell senescence, were reviewed. New targeted therapeutic strategies, including senolytics, antioxidants, and NO-targeting drugs, were evaluated. Results Some underlying expositions warrant further research, including mitochondrial imperfection, telomere shortening, and a rise in pro-inflammatory molecules. Specific agents, such as resveratrol, quercetin, and statins, can potentially reduce vascular stiffness and aging. Their effectiveness in trials has been demonstrated in their impact on oxidative stress and endothelium. Conclusion Knowledge of the molecular mechanisms of vascular aging allows the creation of a pharmacological approach. AIM(s) focused on both senescence and oxidative stress pathways should be considered a paradigm shift in preventing elderly vascular diseases.